First and only FDA-approved treatment of peripheral thyrotoxicosis in adults and pediatric patients with monocarboxylate transporter 8 (MCT8) deficiency ...
In week 37 2026, Festi purchased in total 239,232 own shares for total amount of 72,698,064 ISK as follows: ...
TGS, a leading global provider of energy data and intelligence, routinely publishes a quarterly operational update six ...
At its meeting held on 8 October 2026, the Supervisory Board of Arco Vara AS decided to recall Rait Riim from the Management Board and to appoint Kert ...
UAB INVL Asset Management, taking into account that the Company has formed and not realised the reserve for the purchase of own shares amounting to EUR 9.8 million and considering the resolution of ...
AS “Latvijas Gāze” management buy-out team mobilises financing for the next step. The special purpose vehicle “Energy Investments” SIA, founded by AS ...
Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the "Company") from 28 June 2026 regarding the ...
No. 21 / 2026 Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion ...
Agreement generates non-dilutive funding; PEA evaluating direct shipping planned for H1 2027VANCOUVER, British Columbia, Oct. 21, 2026 (GLOBE NEWSWIRE) -- ...
Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) plans to reduce its workforce during December 2026 with around 85 employees across all ...
DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update: For the third ...
STOCKHOLM, SWEDEN - BTS Group AB (publ), a leading global consultancy specializing in strategy execution, change, and people development, has signed a USD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results